Smith, Miller and Patch

Smith, Miller and Patch was a specialized pharmaceutical company primarily focused on the development and commercialization of ophthalmic products. The company was well-known for its portfolio of eye drops and surgical solutions, including treatments for glaucoma and ocular infections. In 1972, it was acquired by Cooper Laboratories, becoming a key component of their healthcare and eye care divisions. Its legacy products, such as Miochol and Pilocar, played significant roles in ophthalmic surgery and clinical practice for decades. The company's assets were eventually integrated into larger entities like CooperVision and subsequently sold to other major players in the eye care industry.